Structural, functional, and bioinformatics studies reveal a new snake venom homologue phospholipase A 2 class

Proteins: Structure, Function and Bioinformatics

Volumn 79, Issue 1, 2011, Pages 61-78

  Dos Santos, Juliana I ^a,d   Cintra Francischinelli, Mariana ^b   Borges, Rafael J ^a   Fernandes, Carlos A H ^a   Pizzo, Paola ^b   Cintra, Adélia C O ^c   Braz, Antonio S K ^a   Soares, Andreimar M ^c   Fontes, Marcos R M ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSIDADE FEDERAL DO ABC   (Brazil)

Author keywords

Calcium imaging; Myotoxin; Myotube cell culture; Phospholipase A 2; Phylogenetic analysis; X ray crystallography

Indexed keywords

ASPARTIC ACID 49 PHOSPHOLIPASE A2; PHOSPHOLIPASE A2; SNAKE VENOM; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM BINDING; CATALYSIS; CELL CULTURE; CELL VIABILITY; ENZYME ACTIVITY; ENZYME STRUCTURE; IN VITRO STUDY; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; PROTEIN INTERACTION; STRUCTURAL BIOINFORMATICS; X RAY CRYSTALLOGRAPHY;

ANIMALS; BOTHROPS; CELL LINE; COMPUTATIONAL BIOLOGY; CROTALID VENOMS; CRYSTALLOGRAPHY, X-RAY; CYTOTOXINS; GROUP II PHOSPHOLIPASES A2; MICE; MUSCLE FIBERS, SKELETAL; PHOSPHOLIPASES A2; PHYLOGENY; PROTEIN STRUCTURE, TERTIARY; STRUCTURAL HOMOLOGY, PROTEIN; STRUCTURE-ACTIVITY RELATIONSHIP;

CROTALINAE;

EID: 78649775567     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.22858     Document Type: Article

References (108)

1. van Deenen LLM, de Haas GH, Heemskerk CHT. Hydrolysis of synthetic mixed-acid phosphatides by phospholipase A from human pancreas. Biochim Biophys Acta 1963; 67: 295-304.
2. Berk PD, Stump DD. Mechanisms of cellular uptake of long chain free fatty acids. Mol Cell Biochem 1999; 192: 17-31.
3. Gijon MA, Leslie CC. Regulation of arachidonic acid release and cytosolic phospholipase A2 activation. J Leukoc Biol 1999; 65: 330-336.
4. Austin SC, Funk CD. Insight into prostaglandin, leukotriene, and other eicosanoid functions using mice with targeted gene disruptions. Prostaglandins Other Lipid Mediat 1999; 58: 231-252.
5. Bingham CO, III, Austen KF. Phospholipase A2 enzymes in eicosanoid generation. Proc Assoc Am Physicians 1999; 111: 516-524.
6. Balsinde J, Balboa MA, Dennis EA. Identification of a third pathway for arachidonic acid mobilization and prostaglandin production in activated P388D1 macrophage-like cells. J Biol Chem 2000; 275: 22544-22549.
7. Moolenaar WH, Kranenburg O, Postma FR, Zondag GC. Lysophosphatidic acid: G-protein signalling and cellular responses. Curr Opin Cell Biol 1997; 9: 168-173.
8. Arni RK, Ward RJ. Phospholipase A2-a structural review. Toxicon 1996; 34: 827-841.
9. Renetseder R, Dijkstra BW, Huizinga K, Kalk KH, Drenth J. Crystal-structure of bovine pancreatic phospholipase-A2 covalently inhibited by para-bromo-phenacyl-bromide. J Mol Biol 1988; 200: 181-188.
10. Yu BZ, Berg OG, Jain MK. The divalent cation is obligatory for the binding of ligands to the catalytic site of secreted phospholipase A2. Biochemistry 1993; 32: 6485-6492.
11. Six DA, Dennis EA. The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochim Biophys Acta 2000; 1488: 1-19.
12. Kudo I, Murakami M. Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat 2002; 68-69:3-58.
13. White SP, Scott DL, Otwinowski Z, Gelb MH, Sigler PB. Crystal structure of cobra-venom phospholipase A2 in a complex with a transition-state analogue. Science 1990; 250: 1560-1563.
14. Scott DL, White SP, Otwinowski Z, Yuan W, Gelb MH, Sigler PB. Interfacial catalysis: the mechanism of phospholipase A2. Science 1990; 250: 1541-1546.
15. Schaloske RH, Dennis EA. The phospholipase A2 superfamily and its group numbering system. Biochim Biophys Acta 2006; 1761: 1246-1259.
16. Heinrikson RL, Krueger ET, Keim PS. Amino acid sequence of phospholipase A2-alpha from the venom of Crotalus adamanteus. A new classification of phospholipases A2 based upon structural determinants. J Biol Chem 1977; 252: 4913-4921.
17. Calvete JJ, Juarez P, Sanz L. Snake venomics. Strategy and applications. J Mass Spectrom 2007; 42: 1405-1414.
18. Andriao-Escarso SH, Soares AM, Fontes MR, Fuly AL, Correa FM, Rosa JC, Greene LJ, Giglio JR. Structural and functional characterization of an acidic platelet aggregation inhibitor and hypotensive phospholipase A(2) from Bothrops jararacussu snake venom. Biochem Pharmacol 2002; 64: 723-732.
19. Beers SA, Buckland AG, Koduri RS, Cho W, Gelb MH, Wilton DC. The antibacterial properties of secreted phospholipases A2: a major physiological role for the group IIA enzyme that depends on the very high pI of the enzyme to allow penetration of the bacterial cell wall. J Biol Chem 2002; 277: 1788-1793.
20. Bon C, Changeux JP, Jeng TW, Fraenkel-Conrat H. Postsynaptic effects of crotoxin and of its isolated subunits. Eur J Biochem 1979; 99: 471-481.
21. Chang CC, Lee JD, Eaker D, Fohlman J. Short communications the presynaptic neuromuscular blocking action of taipoxin. A comparison with beta-bungarotoxin and crotoxin. Toxicon 1977; 15: 571-576.
22. Gerrard JM, Robinson P, Narvey M, McNicol A. Increased phosphatidic acid and decreased lysophosphatidic acid in response to thrombin is associated with inhibition of platelet aggregation. Biochem Cell Biol 1993; 71: 432-439.
23. Condrea E, Yang CC, Rosenberg P. Lack of correlation between anticoagulant activity and phospholipid hydrolysis by snake venom phospholipases A2. Thromb Haemost 1981; 45: 82-85.
24. Gutiérrez JM, Lomonte B. Phospholipase A2 miotoxins from Bothrops snake venoms. In: Kini RM, editor. Phospholipases A2 Enzymes: Structure, Function, and Mechanism. Chichester: Wiley; 1997. p 321-352.
25. Lloret S, Moreno JJ. Oedema formation and degranulation of mast cells by phospholipase A2 purified from porcine pancreas and snake venoms. Toxicon 1993; 31: 949-956.
26. Paramo L, Lomonte B, Pizarro-Cerda J, Bengoechea JA, Gorvel JP, Moreno E. Bactericidal activity of Lys49 and Asp49 myotoxic phospholipases A2 from Bothrops asper snake venom--synthetic Lys49 myotoxin II-(115-129)-peptide identifies its bactericidal region. Eur J Biochem 1998; 253: 452-461.
27. Rosenberg P. Phospholipases. In: Shyer WT, Mebs D, editors. Handbook of toxinology. New York: Dekker; 1990. p 67-277.
28. Kini RM. Structure-function relationships and mechanism of anticoagulant phospholipase A2 enzymes from snake venoms. Toxicon 2005; 45: 1147-1161.
29. Barbosa PS, Martins AM, Havt A, Toyama DO, Evangelista JS, Ferreira DP, Joazeiro PP, Beriam LO, Toyama MH, Fonteles MC, Monteiro HS. Renal and antibacterial effects induced by myotoxin I and II isolated from Bothrops jararacussu venom. Toxicon 2005; 46: 376-386.
30. Francis B, Gutierrez JM, Lomonte B, Kaiser, II. Myotoxin II from Bothrops asper (Terciopelo) venom is a lysine-49 phospholipase A2. Arch Biochem Biophys 1991; 284: 352-359.
31. Geoghegan P, Angulo Y, Cangelosi A, Diaz M, Lomonte B. Characterization of a basic phospholipase A2-homologue myotoxin isolated from the venom of the snake Bothrops neuwiedii (yarara chica) from Argentina. Toxicon 1999; 37: 1735-1746.
32. Gutierrez JM, Chaves F, Gene JA, Lomonte B, Camacho Z, Schosinsky K. Myonecrosis induced in mice by a basic myotoxin isolated from the venom of the snake Bothrops nummifer (jumping viper) from Costa Rica. Toxicon 1989; 27: 735-745.
33. Gutierrez JM, Lomonte B. Phospholipase A2 myotoxins from Bothrops snake venoms. Toxicon 1995; 33: 1405-1424.
34. Lomonte B, Angulo Y, Calderon L. An overview of lysine-49 phospholipase A2 myotoxins from crotalid snake venoms and their structural determinants of myotoxic action. Toxicon 2003; 42: 885-901.
35. Mebs D, Kuch U, Coronas FIV, Batista CVF, Gumprecht A, Possani LD. Biochemical and biological activities of the venom of the Chinese pitviper Zhaoermia mangshanensis, with the complete amino acid sequence and phylogenetic analysis of a novel Arg49 phospholipase A(2) myotoxin. Toxicon 2006; 47: 797-811.
36. Wei JF, Wei XL, Chen QY, Huang T, Qiao LY, Wang WY, Xiong YL, He SH. N49 phospholipase A2, a unique subgroup of snake venom group II phospholipase A2. Biochim Biophys Acta 2006; 1760: 462-471.
37. Gutierrez JM, Lomonte B, Cerdas L. Isolation and partial characterization of a myotoxin from the venom of the snake Bothrops nummifer. Toxicon 1986; 24: 885-894.
38. Nishioka Sde A, Silveira PV. A clinical and epidemiologic study of 292 cases of lance-headed viper bite in a Brazilian teaching hospital. Am J Trop Med Hyg 1992; 47: 805-810.
39. Otero R, Gutierrez J, Beatriz Mesa M, Duque E, Rodriguez O, Luis Arango J, Gomez F, Toro A, Cano F, Maria Rodriguez L, Caro E, Martinez J, Cornejo W, Mariano Gomez L, Luis Uribe F, Cardenas S, Nunez V, Diaz A. Complications of Bothrops, Porthidium, and Bothriechis snakebites in Colombia. A clinical and epidemiological study of 39 cases attended in a university hospital. Toxicon 2002; 40: 1107-1114.
40. Gutierrez JM, Theakston RD, Warrell DA. Confronting the neglected problem of snake bite envenoming: the need for a global partnership. PLoS Med 2006; 3: e150.
41. Cardoso JL, Fan HW, Franca FO, Jorge MT, Leite RP, Nishioka SA, Avila A, Sano-Martins IS, Tomy SC, Santoro ML, Chudzinski AM, Castro SCB, Kamiguti AS, Kelen EMA, Hirata MH, Mirandola RMS, Theakston RDG, Warrell DA. Randomized comparative trial of three antivenoms in the treatment of envenoming by lance-headed vipers (Bothrops jararaca) in Sao Paulo, Brazil. Q J Med 1993; 86: 315-325.
42. Milani R, Jorge MT, DeCampos FPF, Martins FP, Bousso A, Cardoso JLC, Ribeiro LA, Fan HW, Franca FOS, SanoMartins IS, Cardoso D, Fernandez IDOF, Fernandes JC, Aldred VL, Sandoval MP, Puorto G, Theakston RDG, Warrell DA. Snake bites by the jararacucu (Bothrops jararacussu): clinicopathological studies of 29 proven cases in Sao Paulo State, Brazil. QJM-Mon J Assoc Physicians 1997; 90: 323-334.
43. Lomonte B, Leon G, Angulo Y, Rucavado A, Nunez V. Neutralization of Bothrops asper venom by antibodies, natural products and synthetic drugs: contributions to understanding snakebite envenomings and their treatment. Toxicon 2009; 54: 1012-1028.
44. Ward RJ, Chioato L, de Oliveira AH, Ruller R, Sa JM. Active-site mutagenesis of a Lys49-phospholipase A2: biological and membrane-disrupting activities in the absence of catalysis. Biochem J 2002; 362(Part 1): 89-96.
45. Maraganore JM, Merutka G, Cho W, Welches W, Kezdy FJ, Heinrikson RL. A new class of phospholipases A2 with lysine in place of aspartate 49. Functional consequences for calcium and substrate binding. J Biol Chem 1984; 259: 13839-13843.
46. dos Santos JI, Fernandes CA, Magro AJ, Fontes MR. The intriguing phospholipases A2 homologues: relevant structural features on myotoxicity and catalytic inactivity. Protein Pept Lett 2009; 16: 887-893.
47. Chioato L, de Oliveira AHC, Ruller R, Sa JM, Ward RJ. Distinct sites for myotoxic and membrane-damaging activities in the C-terminal region of a Lys(49)-phospholipase A(2). Biochem J 2002; 366: 971-976.
48. Chioato L, Aragao EA, Ferreira TL, de Medeiros AI, Faccioli LH, Ward RJ. Mapping of the structural determinants of artificial and biological membrane damaging activities of a Lys49 phospholipase A(2) by scanning alanine mutagenesis. Biochim Et Biophys Acta-Biomemb 2007; 1768: 1247-1257.
49. Nunez CE, Angulo Y, Lomonte B. Identification of the myotoxic site of the Lys49 phospholipase A(2) from Agkistrodon piscivorus piscivorus snake venom: synthetic C-terminal peptides from Lys49, but not from Asp49 myotoxins, exert membrane-damaging activities. Toxicon 2001; 39: 1587-1594.
50. Ward RJ, Alves AR, Ruggiero Neto J, Arni RK, Casari G. A SequenceSpace analysis of Lys49 phopholipases A2: clues towards identification of residues involved in a novel mechanism of membrane damage and in myotoxicity. Protein Eng 1998; 11: 285-294.
51. Cintra-Francischinelli M, Pizzo P, Angulo Y, Gutierrez JM, Montecucco C, Lomonte B. The C-terminal region of a Lys49 myotoxin mediates Ca2+ influx in C2C12 myotubes. Toxicon 2010; 55: 590-596.
52. Calderon L, Lomonte B. Immunochemical characterization and role in toxic activities of region 115-129 of myotoxin II, a Lys49 phospholipase A2 from Bothrops asper snake venom. Arch Biochem Biophys 1998; 358: 343-350.
53. Calderon L, Lomonte B. Inhibition of the myotoxic activity of Bothrops asper myotoxin II in mice by immunization with its synthetic 13-mer peptide 115-129. Toxicon 1999; 37: 683-687.
54. Lomonte B, Pizarro-Cerda J, Angulo Y, Gorvel JP, Moreno E. Tyr-->Trp-substituted peptide 115-129 of a Lys49 phospholipase A(2) expresses enhanced membrane-damaging activities and reproduces its in vivo myotoxic effect. Biochim Biophys Acta 1999; 1461: 19-26.
55. Lomonte B, Angulo Y, Santamaria C. Comparative study of synthetic peptides corresponding to region 115-129 in Lys49 myotoxic phospholipases A2 from snake venoms. Toxicon 2003; 42: 307-312.
56. dos Santos JI, Soares AM, Fontes MR. Comparative structural studies on Lys49-phospholipases A(2) from Bothrops genus reveal their myotoxic site. J Struct Biol 2009; 167: 106-116.
57. Homsi-Brandeburgo MI, Queiroz LS, Santo-Neto H, Rodrigues-Simioni L, Giglio JR. Fractionation of Bothrops jararacussu snake venom: partial chemical characterization and biological activity of bothropstoxin. Toxicon 1988; 26: 615-627.
58. Gutierrez JM, Nunez J, Diaz C, Cintra AC, Homsi-Brandeburgo MI, Giglio JR. Skeletal muscle degeneration and regeneration after injection of bothropstoxin-II, a phospholipase A2 isolated from the venom of the snake Bothrops jararacussu. Exp Mol Pathol 1991; 55: 217-229.
59. Pereira MF, Novello JC, Cintra AC, Giglio JR, Landucci ET, Oliveira B, Marangoni S. The amino acid sequence of bothropstoxin-II, an Asp-49 myotoxin from Bothrops jararacussu (Jararacucu) venom with low phospholipase A2 activity. J Protein Chem 1998; 17: 381-386.
60. Toyama MH, Costa PD, Novello JC, de Oliveira B, Giglio JR, da Cruz-Hofling MA, Marangoni S. Purification and amino acid sequence of MP-III 4R D49 phospholipase A2 from Bothrops pirajai snake venom, a toxin with moderate PLA2 and anticoagulant activities and high myotoxic activity. J Protein Chem 1999; 18: 371-378.
61. Correa LC, Marchi-Salvador DP, Cintra AC, Sampaio SV, Soares AM, Fontes MR. Crystal structure of a myotoxic Asp49-phospholipase A2 with low catalytic activity: insights into Ca2+-independent catalytic mechanism. Biochim Biophys Acta 2008; 1784: 591-599.
62. Rigden DJ, Hwa LW, Marangoni S, Toyama MH, Polikarpov I. The structure of the D49 phospholipase A2 piratoxin III from Bothrops pirajai reveals unprecedented structural displacement of the calcium-binding loop: possible relationship to cooperative substrate binding. Acta Crystallogr D Biol Crystallogr 2003; 59(Part 2): 255-262.
63. Bonfim VL, de Carvalho DD, Ponce-Soto LA, Kassab BH, Marangoni S. Toxicity of phospholipases A2 D49 (6-1 and 6-2) and K49 (Bj-VII) from Bothrops jararacussu venom. Cell Biol Toxicol 2009; 25: 523-532.
64. Fuly AL, Soares AM, Marcussi S, Giglio JR, Guimaraes JA. Signal transduction pathways involved in the platelet aggregation induced by a D-49 phospholipase A2 isolated from Bothrops jararacussu snake venom. Biochimie 2004; 86: 731-739.
65. McPherson A. Introduction to macromolecular crystallography. Hoboken: Wiley-Liss; 2003. 237 p.
66. Otwinowski Z, Minor W. Processing of X-ray diffraction data collected in oscillation mode. Macromol Crystallogr A 1997; 276: 307-326.
67. Brunger AT. Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature 1992; 355: 472-475.
68. Murshudov GN, Vagin AA, Dodson EJ. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 1997; 53(Part 3): 240-255.
69. Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 2004; 60(Part 12, Part 1): 2126-2132.
70. Brunger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse-Kunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS, Read RJ, Rice LM, Simonson T, Warren GL. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr Sect D-Biol Crystallogr 1998; 54: 905-921.
71. Harding MM. Geometry of metal-ligand interactions in proteins. Acta Crystallogr D Biol Crystallogr 2001; 57 (Part 3): 401-411.
72. Harding MM. The geometry of metal-ligand interactions relevant to proteins. II. Angles at the metal atom, additional weak metal-donor interactions. Acta Crystallogr D Biol Crystallogr 2000; 56(Part 7): 857-867.
73. Fraústo da Silva JJR, Willians RJP. The Biological Chemistry of the Elements-The Inorganic Chemistry of Life. Oxford University Press: Oxford; 1991. 561 p.
74. Laskowski RA, Macarthur MW, Moss DS, Thornton JM. Procheck-a program to check the stereochemical quality of protein structures. J Appl Crystallogr 1993; 26: 283-291.
75. Jones TA, Bergdoll M, Kjeldgaard M. O: a macromolecule modeling environment. In: Bugg C, Ealick SE, editors. Crystallographic and Modeling Methods in Molecular Design. New York: Springer-Verlag; 1990. p 189-195.
76. Krissinel E, Henrick K. Inference of macromolecular assemblies from crystalline state. J Mol Biol 2007; 372: 774-797.
77. DeLano WL. The PyMOL molecular graphics system. San Carlos, CA: DeLano Scientific LLC; 2002.
78. Schwartz AS, Pachter L. Multiple alignment by sequence annealing. Bioinformatics 2007; 23: e24-e29.
79. Huelsenbeck JP, Ronquist F. MRBAYES: Bayesian inference of phylogenetic trees. Bioinformatics 2001; 17: 754-755.
80. Maddison WP, Maddison DR. Mesquite: a modular system for evolutionary analysis. Version 2.72. 2009. Available at:
81. Kaiser, II, Gutierrez JM, Plummer D, Aird SD, Odell GV. The amino acid sequence of a myotoxic phospholipase from the venom of Bothrops asper. Arch Biochem Biophys 1990; 278: 319-325.
82. Lomonte B, Gutierrez JM. A new muscle damaging toxin, myotoxin II, from the venom of the snake Bothrops asper (terciopelo). Toxicon 1989; 27: 725-733.
83. Cintra AC, Marangoni S, Oliveira B, Giglio JR. Bothropstoxin-I: amino acid sequence and function. J Protein Chem 1993; 12: 57-64.
84. Arni RK, Ward RJ, Gutierrez JM, Tulinsky A. Structure of a calcium-independent phospholipase-like myotoxic protein from Bothrops asper venom. Acta Crystallogr D Biol Crystallogr 1995; 51(Part 3): 311-317.
85. Soares AM, Rodrigues VM, Homsi-Brandeburgo MI, Toyama MH, Lombardi FR, Arni RK, Giglio JR. A rapid procedure for the isolation of the Lys-49 myotoxin II from Bothrops moojeni (caissaca) venom: biochemical characterization, crystallization, myotoxic and edematogenic activity. Toxicon 1998; 36: 503-514.
86. Watanabe L, Soares AM, Ward RJ, Fontes MRM, Arni RK. Structural insights for fatty acid binding in a Lys49-phospholipase A(2): crystal structure of myotoxin II from Bothrops molojeni complexed with stearic acid. Biochimie 2005; 87: 161-167.
87. Angulo Y, Gutierrez JM, Soares AM, Cho W, Lomonte B. Myotoxic and cytolytic activities of dimeric Lys49 phospholipase A(2) homologues are reduced, but not abolished, by a pH-induced dissociation. Toxicon 2005; 46: 291-296.
88. Murakami MT, Vicoti MM, Abrego JRB, Lourenzoni MR, Cintra ACO, Arruda EZ, Tomaz MA, Melo PA, Arni RK. Interfacial surface charge and free accessibility to the PLA(2)-active site-like region are essential requirements for the activity of Lys49 PLA(2) homologues. Toxicon 2007; 49: 378-387.
89. Cintra-Francischinelli M, Pizzo P, Rodrigues-Simioni L, Ponce-Soto LA, Rossetto O, Lomonte B, Gutierrez JM, Pozzan T, Montecucco C. Calcium imaging of muscle cells treated with snake myotoxins reveals toxin synergism and presence of acceptors. Cell Mol Life Sci 2009; 66: 1718-1728.
90. Matthews BW. Solvent content of protein crystals. J Mol Biol 1968; 33: 491-497.
91. Murakami MT, Arruda EZ, Melo PA, Martinez AB, Calil-Elias S, Tomaz MA, Lomonte B, Gutierrez JM, Arni RK. Inhibition of myotoxic activity of Bothrops asper myotoxin II by the anti-trypanosomal drug surarnin. J Mol Biol 2005; 350: 416-426.
92. Wang XQ, Yang J, Gui LL, Lin ZJ, Chen YC, Zhou YC. Crystal structure of an acidic phospholipase A2 from the venom of Agkistrodon halys pallas at 2.0 A resolution. J Mol Biol 1996; 255: 669-676.
93. Gu L, Zhang H, Song S, Zhou Y, Lin Z. Structure of an acidic phospholipase A2 from the venom of Deinagkistrodon acutus. Acta Crystallogr D Biol Crystallogr 2002; 58(Part 1): 104-110.
94. Chandra V, Kaur P, Jasti J, Betzel C, Singh TP. Regulation of catalytic function by molecular association: structure of phospholipase A2 from Daboia russelli pulchella (DPLA2) at 1.9 A resolution. Acta Crystallogr D Biol Crystallogr 2001; 57(Part 12): 1793-1798.
95. Scott DL, Otwinowski Z, Gelb MH, Sigler PB. Crystal structure of bee-venom phospholipase A2 in a complex with a transition-state analogue. Science 1990; 250: 1563-1566.
96. Zhou X, Tan TC, Valiyaveettil S, Go ML, Kini RM, Velazquez-Campoy A, Sivaraman J. Structural characterization of myotoxic ecarpholin S from Echis carinatus venom. Biophys J 2008; 95: 3366-3380.
97. Arni RK, Fontes MR, Barberato C, Gutierrez JM, Diaz C, Ward RJ. Crystal structure of myotoxin II, a monomeric Lys49-phospholipase A2 homologue isolated from the venom of Cerrophidion (Bothrops) godmani. Arch Biochem Biophys 1999; 366: 177-182.
98. Magro AJ, Murakami MT, Marcussi S, Soares AM, Arni RK, Fontes MR. Crystal structure of an acidic platelet aggregation inhibitor and hypotensive phospholipase A2 in the monomeric and dimeric states: insights into its oligomeric state. Biochem Biophys Res Commun 2004; 323: 24-31.
99. Magro AJ, Soares AM, Giglio JR, Fontes MR. Crystal structures of BnSP-7 and BnSP-6, two Lys49-phospholipases A(2): quaternary structure and inhibition mechanism insights. Biochem Biophys Res Commun 2003; 311: 713-720.
100. Marchi-Salvador DP, Correa LC, Magro AJ, Oliveira CZ, Soares AM, Fontes MR. Insights into the role of oligomeric state on the biological activities of crotoxin: crystal structure of a tetrameric phospholipase A2 formed by two isoforms of crotoxin B from Crotalus durissus terrificus venom. Proteins 2008; 72: 883-891.
101. Murakami MT, Melo CC, Angulo Y, Lomonte B, Arni RK. Structure of myotoxin II, a catalytically inactive Lys49 phospholipase A(2) homologue from Atropoides nummifer venom. Acta Crystallogr Sect F: Struct Biol Cryst Commun 2006; 62: 423-426.
102. Murakami MT, Gabdoulkhakov A, Genov N, Cintra ACO, Betzel C, Arni RK. Insights into metal ion binding in phospholipases A(2): ultra high-resolution crystal structures of an acidic phospholipase A(2) in the Ca2+ free and bound states. Biochimie 2006; 88: 543-549.
103. Marchi-Salvador DP, Fernandes CA, Silveira LB, Soares AM, Fontes MR. Crystal structure of a phospholipase A(2) homologue complexed with p-bromophenacyl bromide reveals important structural changes associated with the inhibition of myotoxic activity. Biochim Biophys Acta 2009; 1794: 1583-1590.
104. Magro AJ, Fernandes CA, dos Santos JI, Fontes MR. Influence of quaternary conformation on the biological activities of the Asp49-phospholipases A2s from snake venoms. Protein Pept Lett 2009; 16: 852-859.
105. Ohno M, Chijiwa T, Oda-Ueda N, Ogawa T, Hattori S. Molecular evolution of myotoxic phospholipases A2 from snake venom. Toxicon 2003; 42: 841-854.
106. Chang Y, Li Y, Bao Y, An L. Neurotoxic activity of Gln49 phospholipase A(2) from Gloydius ussuriensis snake venom. J Appl Toxicol 2007; 27: 447-452.
107. Rodrigues RS, Izidoro LFM, Teixeira SS, Silveira LB, Hamaguchi A, Homsi-Brandeburgo MI, Selistre-de-Araujo HS, Giglio JR, Fuly AL, Soares AM, Rodrigues VM. Isolation and functional characterization of a new myotoxic acidic phospholipase A(2) from Bothrops pauloensis snake venom. Toxicon 2007; 50: 153-165.
108. Santos-Filho NA, Silveira LB, Oliveira CZ, Bernardes CP, Menaldo DL, Fuly AL, Arantes EC, Sampaio SV, Mamede CC, Beletti ME, de Oliveira F, Soares AM. A new acidic myotoxic, anti-platelet and prostaglandin I2 inductor phospholipase A2 isolated from Bothrops moojeni snake venom. Toxicon 2008; 52: 908-917.